Roy Herbst
Director/Board Member chez SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Fortune : - $ au 31/03/2024
Profil
Roy Steven Herbst is currently the Director at the American Association for Cancer Research, the Chief-Medical Oncology & Director-Translational at Yale Cancer Center, and the Director at the International Association for the Study of Lung Cancer.
He is also serving as an Independent Non-Executive Director at Shanghai Junshi Biosciences Co., Ltd.
since 2018 and at Immunocore Holdings Plc since 2021.
Additionally, he holds the position of Non-Executive Director at Immunocore Ltd.
Dr. Herbst is a Professor at The University of Texas at Austin and a Member of the National Cancer Institute.
He previously worked as the Director at ApoCell, Inc. and held the position of Professor at The University of Texas M.D.
Anderson Cancer Center from 1991 to 2011.
He also served as a Professor-Medicine & Pharmacology at Ensign College.
Dr. Herbst completed his graduate degree at Harvard University in 1997, with additional graduate degrees from Yale University in 1984.
He obtained his doctorate degrees from The Rockefeller University in 1990 and Weill Cornell Medical College in 1991.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
-.--% | 02/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Roy Herbst
| Sociétés | Poste | Début |
|---|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Director/Board Member | 24/06/2018 |
| IMMUNOCORE HOLDINGS PLC | Director/Board Member | 28/01/2021 |
| The University of Texas at Austin | Corporate Officer/Principal | 01/10/2009 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
| International Association for the Study of Lung Cancer | Director/Board Member | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Director/Board Member | - |
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Corporate Officer/Principal | - |
| Smilow Cancer Hospital Care Center | Corporate Officer/Principal | - |
Anciens postes connus de Roy Herbst
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Roy Herbst
| Harvard University | Graduate Degree |
| Yale University | Graduate Degree |
| The Rockefeller University | Doctorate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Entreprise privées | 8 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
Yale Cancer Center
Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Health Services |
ApoCell, Inc.
 ApoCell, Inc. Medical/Nursing ServicesHealth Services ApoCell, Inc. engages in molecular biomarker detection. It offers platform technologies, assay development, circulating tumor cells, genomics, flow cytometry, FISH and immunohistochemistry, immunofluorescence image analysis and cytokine Profiling services. The company was founded by Darren W. Davis in 2004 and is headquartered in Houston, TX. | Health Services |
| International Association for the Study of Lung Cancer | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |
| Smilow Cancer Hospital Care Center |
